Cargando…

Effects of Metformin, Insulin on Hematological Parameters of COVID-19 Patients with Type 2 Diabetes

BACKGROUND: COVID-19 infection caused by SARS-COV-2 can result in multi-organ injuries and significant mortality in severe and critical patients, particularly those with type 2 diabetes as a comorbidity. Metformin and insulin are the main diabetes medications that affect the outcome of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petakh, Pavlo, Griga, Vasilij, Mohammed, Issah Bin, Loshak, Kateryna, Poliak, Ivan, Kamyshnyiy, Aleksandr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760238/ https://www.ncbi.nlm.nih.gov/pubmed/36545453 http://dx.doi.org/10.5455/medarh.2022.76.329-332

Ejemplares similares

Effects of metformin on the gut microbiota: A systematic review
por: Pavlo Petakh, et al.
Publicado: (2023)

Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
por: Petakh, Pavlo, et al.
Publicado: (2023)

The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
por: Petakh, Pavlo, et al.
Publicado: (2023)

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023)

Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
por: Petakh, Pavlo, et al.
Publicado: (2023)

Risks of outbreaks: The health concerns of internally displaced persons in Transcarpathia, Ukraine
por: Petakh, Pavlo, et al.
Publicado: (2023)

Almond Consumption and Inflammatory Biomarkers: A Need for Further Investigation
por: Petakh, Pavlo, et al.
Publicado: (2023)

Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
por: Petakh, Pavlo, et al.
Publicado: (2022)

Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
por: Petakh, Pavlo, et al.
Publicado: (2022)

Infectious diseases during the Russian-Ukrainian war - Morbidity in the Transcarpathian region as a marker of epidemic danger on the EU border
por: Petakh, Pavlo, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors Target B Lymphocytes
por: Upfold, Nikki Lyn Esnardo, et al.
Publicado: (2023)

Gut microbiota status in leptospirosis: An unrecognized player?
por: Petakh, Pavlo, et al.
Publicado: (2022)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Case report: Azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in Ukraine
por: Kryzhevskyi, Vadym, et al.
Publicado: (2023)

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Monami, Matteo, et al.
Publicado: (2011)

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016)

Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial
por: Yang, Daizhi, et al.
Publicado: (2020)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Exploring the Correlates of Hematological Parameters With Early Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Chollangi, Susmitha, et al.
Publicado: (2023)

Can hematological parameters in type 2 diabetes predict microvascular complication development?
por: Onalan, Erhan, et al.
Publicado: (2019)

Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
por: Priya, Gagan, et al.
Publicado: (2017)

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
por: Alavudeen, Sirajudeen Shaik, et al.
Publicado: (2020)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Relationship Between Hematological Parameters and Glycemic Control in Type 2 Diabetes Mellitus Patients
por: Milosevic, Dragana, et al.
Publicado: (2019)

Correlation of non-clinical parameters with the hematological indices in type 2 diabetic Mellitus patients
por: Sampathkumar, Vamitha Paneerselvam, et al.
Publicado: (2021)

Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis
por: Balsells, Montserrat, et al.
Publicado: (2015)

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
por: Seghieri, Marta, et al.
Publicado: (2018)

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
por: Shankar, R Ravi, et al.
Publicado: (2016)

Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin
por: Cai, Tingting, et al.
Publicado: (2021)

Metformin - its anti-cancer effects in hematologic malignancies
por: Podhorecka, Monika
Publicado: (2021)

Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
por: Miele, Luca, et al.
Publicado: (2015)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents
por: Sikorskaya, Katsiaryna, et al.
Publicado: (2021)

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
por: Hu, Yun, et al.
Publicado: (2021)

Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus
por: Kimura, Tomohiko, et al.
Publicado: (2021)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hf0mmbpbf9q3m4fdc768iceaot